Cochrane Abstracts
Continuous versus intermittent beta‐agonists for acute asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Continuous Versus Intermittent Beta‐agonists for Acute Asthma." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438855/0/Continuous_versus_intermittent_beta‐agonists_for_acute_asthma.
Continuous versus intermittent beta‐agonists for acute asthma. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438855/0/Continuous_versus_intermittent_beta‐agonists_for_acute_asthma. Accessed January 24, 2026.
Continuous versus intermittent beta‐agonists for acute asthma. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438855/0/Continuous_versus_intermittent_beta‐agonists_for_acute_asthma
Continuous Versus Intermittent Beta‐agonists for Acute Asthma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438855/0/Continuous_versus_intermittent_beta‐agonists_for_acute_asthma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Continuous versus intermittent beta‐agonists for acute asthma
ID - 438855
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438855/0/Continuous_versus_intermittent_beta‐agonists_for_acute_asthma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
